Login       My Wishlist
  My Cart
$0.00 / 0 items
 
Diseasome
Seeking to Better Understands Disease and How to Manage It
International Access
Global Shipping Options Available
  Our Catalog   Pharmacology   Cardiovascular

Cardiovascular - 57 - Page 4 - Blowout Sale! Save up to 92%


Blowout Sale! Up to 92% off on Cardiovascular at Diseasome, Page 4. Top brands include Brand: CRC Press, Marcel Dekker Inc, Just H, Birkhäuser, Springer, Churchill Livingstone, Excerpta Medica, Wiley-Interscience, Wiley-Liss, Brand: Kluwer Academic Publishers, Brand: Springer, & Robert M Mentzer Jr. Hurry! Limited time offers. Offers valid only while supplies last.



Electrophysiology and Pharmacology of the Heart: A Clinical Guide
Electrophysiology and Pharmacology of the Heart: A Clinical Guide
By Brand: CRC Press
In Stock
$299.95
$217.52
You Save: 27%

ean: 9780824784492, isbn: 0824784499,

4.6 out of 5 stars with 26 reviews
Written for a broad audience of students and clinicians, this text is divided into four parts addressing: 1) the four major techniques that can be used to investigate the electrical behavior of the heart, cardiac cells, and the ion channels of those cells; 2) the electrophysiology of the five majorUsed Book in Good Condition.


Cardiotonic Drugs: A Clinical Review (Fundamental and Clinical Cardiology)
Cardiotonic Drugs: A Clinical Review (Fundamental and Clinical Cardiology)
By Marcel Dekker Inc
In Stock
$155.00
$147.59
You Save: 5%

ean: 9780824784713, isbn: 0824784715,

4.7 out of 5 stars with 13 reviews
.


Inotropic Stimulation and Myocardial Energetics
Inotropic Stimulation and Myocardial Energetics
By Just H
In Stock
$109.00
$100.00
You Save: 8%

mpn: black & white illustrations, ean: 9783662079102, isbn: 3662079100,

4.7 out of 5 stars with 51 reviews
Inotropic stimulation of the myocardium, as well as vasodilation and diuresis as essential principles in the treatment of congestive heart failure have recently met with considerable criticism and reevaluation. It is generally agreed that unloading of the heart, either through vasodilation and/or diuresis, improves the working conditions of the dilated, failing heart. It reduces myocar­ dial oxygen consumption through reduction of chamber radius and, thereby, wall tension as the major


HMG-CoA Reductase Inhibitors (Milestones in Drug Therapy)
HMG-CoA Reductase Inhibitors (Milestones in Drug Therapy)
By Birkhäuser
In Stock
$199.99

ean: 9783764363079, isbn: 376436307X,

4.2 out of 5 stars with 276 reviews
HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development


Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular (Methodological Surveys in Biochemistry and Analysis) (v. 18)
Bioanalysis of Drugs and Metabolites, Especially Anti-Inflammatory and Cardiovascular (Methodological Surveys in Biochemistry and Analysis) (v. 18)
By Springer
In Stock
$199.99
$183.79
You Save: 8%

ean: 9780306429965, isbn: 0306429969,

4.2 out of 5 stars with 45 reviews
vi as did non-appreciation that % values for bought-in solutions (notably ammonia) may be on a weight basis, not made evident by the manufacturer. Notwithstanding the shortcomings or lateness of some texts, authors are thanked for compiling them amidst other pressures. Elsevier and the American Chemical Society are also thanked, for Figures now reproduced with source acknowledgement. This Editor has generally respected authors' phrasing, whilst shuddering when the term 'incubate' is encountered


Beta-Blockers in Clinical Practice
Beta-Blockers in Clinical Practice
By Churchill Livingstone
In Stock
$185.00

ean: 9780443029882, isbn: 0443029881,

4.6 out of 5 stars with 155 reviews
.


Pharmacology and Management of Hypertension (Contemporary Issues in Nephrology)
Pharmacology and Management of Hypertension (Contemporary Issues in Nephrology)
By Churchill Livingstone
In Stock
$125.00
$59.44
You Save: 52%

ean: 9780443088964, isbn: 0443088969,

4.3 out of 5 stars with 48 reviews
A concise, yet comprehensive volume focusing on pharmacology and specific treatment options for hypertensive states. Intended for nephrologists, cardiologists and internists, the book provides an overview of the subject written by a leader in the field..


A-Adrenoceptors: Signal Transduction, Ionic Channels, and Effector Organs : Proceedings of the 9/10th A-Adrenoceptors Conference Tokyo, August 30-31 (Current Clinical Practice)
By Excerpta Medica
In Stock
$156.25

ean: 9780444897275, isbn: 0444897275,

4.9 out of 5 stars with 59 reviews
Along with others in the series, this book presents and discusses the results of research and exchange information on alpha-adrenoceptors from the viewpoint of both basic and clinical medicine. This volume focuses on the latest research on the structure, function and regulation of alpha-adrenoceptors, receptor-coupled ionic channels, and signal transduction and effectors of alpha-adrenoceptors. The book should be of interest to pharmacologists, molecular biologists and neurologists, and hopes


Cardiovascular Drugs (Chemistry and Pharmacology of Drugs)
Cardiovascular Drugs (Chemistry and Pharmacology of Drugs)
By Wiley-Interscience
In Stock
$117.83

ean: 9780471092285, isbn: 0471092282,

4.1 out of 5 stars with 272 reviews
A comprehensive treatment of the chemistry, biochemistry, pharmacology, and test methodology of drugs used to treat the major cardiac diseases. Outlines the basic aspects of cardiac dysfunction, giving an analysis of some common threads linking cardiac disease states. Provides specific information on screening methodology, including in vitro and whole animal models; extensive coverage of drug classes, including beta-adrenoceptor antagonists, calcium antagonists, antianginals, cardiotonic


Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use
Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use
By Wiley-Liss
In Stock
$136.50

ean: 9780471111955, isbn: 0471111953,

4.9 out of 5 stars with 289 reviews
About the Book ACE inhibitors are justly regarded as the most important advance in cardiac drug therapy since the advent of calcium channel antagonist drugs. Acting basically as inhibitors of the renin-angiotensin vasoconstrictor system, these agents have grown in importance to become among the therapeutic agents first choice for hypertension and a cornerstone of therapy in congestive heart failure. Recent studies show that they can also prevent overt heart failure and reinfarction, and


Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... (Developments in Cardiovascular Medicine)
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... (Developments in Cardiovascular Medicine)
By Brand: Kluwer Academic Publishers
In Stock
$319.00
$315.00
You Save: 1%

ean: 9780792302940, isbn: 079230294X,

4.3 out of 5 stars with 14 reviews
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents. The use of thrombolytic agents has become one


Pathophysiology and Pharmacology of Heart Disease: Proceedings of the symposium held by the Indian section of the International Society for Heart ... (Developments in Cardiovascular Medicine)
Pathophysiology and Pharmacology of Heart Disease: Proceedings of the symposium held by the Indian section of the International Society for Heart ... (Developments in Cardiovascular Medicine)
By Brand: Springer
In Stock
$219.99

ean: 9780792303671, isbn: 0792303679,

4.9 out of 5 stars with 50 reviews
Research at the molecular and the cellular level has greatly enhanced our understanding of the pathogenesis and management of heart disease. Valuable contributions, towards this end, have been made by scientists from different dis­ ciplines including biochemistry, physiology, pathology, molecular biology and biophysics. We felt that it would be of interest and value to bring together ex­ perts from diverse specialities to present their work and to discuss the common problems encountered in


Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and ... (Developments in Cardiovascular Medicine)
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and ... (Developments in Cardiovascular Medicine)
By Brand: Springer
In Stock
$219.99

ean: 9780792307563, isbn: 0792307569,

4.8 out of 5 stars with 24 reviews
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this


Nitrates Updated: Current Use in Angina, Ischemia, Infarction and Failure
Nitrates Updated: Current Use in Angina, Ischemia, Infarction and Failure
By Brand: Springer
In Stock
$219.99

ean: 9780792334668, isbn: 0792334663,

4.6 out of 5 stars with 24 reviews
Nitrates remain among the most commonly used therapeutic agents in cardiology. That they can re­ lieve pain in angina pectoris has been known at least since 1867, when Lauder Brunton described their clinical use. Now, almost 130 years later, we are constantly learning more about their optimal use in anginal syndromes. For example, there is no doubt that nitrate tolerance occurs, but equally no doubt that certain drug dosages help to attenuate such toler­ ance. Thus, our understanding of


Adenosine, Cardioprotein and Its Clinical Application
Adenosine, Cardioprotein and Its Clinical Application
By Robert M Mentzer Jr
In Stock
$219.00
$213.76
You Save: 2%

ean: 9780792399544, isbn: 0792399544,

4.0 out of 5 stars with 10 reviews
The immense growth in the number of articles on adenosine cardioprotection in recent years has been related in large part to the hypothesis that adenosine plays a role in ischemic preconditioning. Ischemic preconditioning is the phenomenon in which a brief period of ischemia (and reperfusion) prior to a more prolonged occlusion reduces myocardial infarct size. This form of myocardial protection has received much interest because ischemic preconditioning has been shown to be the most potent


Efficacy of Myocardial Infarction Therapy: An Evaluation of Clinical Trials Evidence
Efficacy of Myocardial Infarction Therapy: An Evaluation of Clinical Trials Evidence
By Brand: CRC Press
In Stock
$229.95
$17.45
You Save: 92%

ean: 9780824719326, isbn: 0824719328,

4.2 out of 5 stars with 60 reviews
In this unique reference, nearly 50 principal investigators of major clinical trials of myocardial infarction (MI) therapy explain how their work has contributed to the current standard of care. Includes the work of researchers at an impressive range of distinguished institutions worldwide! Providing the basis for treatment guidelines, Efficacy of Myocardial Infarction Therapyexamines clinical trials that have established the efficacy of particular therapies, including acute coronary


Beta-Blockers and Cardiac Arrhythmias (Fundamental and Clinical Cardiology)
Beta-Blockers and Cardiac Arrhythmias (Fundamental and Clinical Cardiology)
By Brand: CRC Press
In Stock
$229.95
$163.13
You Save: 29%

ean: 9780824784508, isbn: 0824784502,

4.3 out of 5 stars with 47 reviews
Beta-blockers and Cardiac Arrhythmias comprehensively reviews all available data on the antiarrhythmic actions of beta-blocking agents and places special emphasis on their clinical applications in patients with cardiac tachyarrhythmias.;Supplying the most up-to-date information on the fundamental mechanisms of action of beta-blockers and their role in various clinical subsets of patients with cardiac arrhythmias, Beta-Blockers and Cardiac Arrhythmias furnishes clinically meaningful reports on


Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases (Fundamental and Clinical Cardiology)
Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases (Fundamental and Clinical Cardiology)
By Marcel Dekker Inc
In Stock
$145.00
$90.58
You Save: 38%

ean: 9780824791742, isbn: 0824791746,

4.0 out of 5 stars with 40 reviews
Provides information for both basic scientists and specialist clinicians on the new class of heparin fractions developed in France in the 1980s and now gradually replacing the old unfractionated heparin for the treatment and prevention of venous thromboembolism. Among the topics are the pharmacology, the mode of action in plasma, interaction with platelets, and prevention following various kinds of surgery. Annotation copyright Book News, Inc. Portland, Or..


AnticoagulantsPhysiologic, Pathologic, and Pharmacologic
AnticoagulantsPhysiologic, Pathologic, and Pharmacologic
By Brand: CRC Press
In Stock
$378.00

ean: 9780849347627, isbn: 0849347629,

4.1 out of 5 stars with 12 reviews
Anticoagulants provides authoritative reviews of proteins C and S, antithrombin III, and the recently described tissue factor pathway inhibitor. There are extensive discussions of pathologic anticoagulants, such as those found in patients with congenital clotting factor deficiencies or those that arise de novo in previously well individuals. Detailed clinical advice is presented for the management of patients with these inhibitors. A chapter on ''lupus'' anticoagulants provides a comprehensive


Drugs and the Delivery of Oxygen to Tissues
Drugs and the Delivery of Oxygen to Tissues
By Brand: CRC Press
In Stock
$509.00
$244.62
You Save: 52%

ean: 9780849366567, isbn: 0849366569,

4.6 out of 5 stars with 30 reviews
This rare and unique work consists of a broad overview of hyperviscosity, blood cell deformability, and platelet aggregation. These topics are written in combination with a comprehensive review of drugs bring developed to treat impaired oxygen delivery to tissue. It devotes much attention to the pathophysiology and pharmacology of platelet and red cell involvement. This easy-to-use volume describes in detail techniques for studying microcirculatory functional efficiency, blood cell rheology,



Viewing Page 4 of 6

View more products in Pharmacology.
Feel free to Browse Our Catalog.



Privacy Policy / Terms of Service / Accessibility Statement
© 2019 - diseasome.org. All Rights Reserved.